Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Consumer Analyst Group of New York Conference Transcript

Feb 19, 2019 / 02:00PM GMT
Release Date Price: €119.75 (-0.59%)
Andrew Lazar
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

Good morning. Thank you for rejoining us. We're fortunate to have with us once again this year the management team of Johnson & Johnson's Worldwide Consumer Group. Specifically for purposes of this presentation, Alison Lewis, who is Chief Marketing Officer of J&J Consumer. Johnson & Johnson's Consumer business delivered $13.9 billion in global sales in 2018, returning to above-market growth, an acceleration that was fueled by innovative category-growing products as well as geographic expansion of multiple brands. Since last year's presentation, the company also announced the acquisitions of 2 new companies in fast-growing categories, Zarbee's in the nationally based OTC space and Dr.Ci:Labo in the premium beauty space. So please join me in welcoming Alison and J&J to the conference.

Alison Lewis
Johnson & Johnson Consumer Inc. - Global CMO

Thank you. So it's great to be here with all of you again this year to share a little bit more about Johnson &

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot